The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Gut Microbe, Prevotella copri, Implicated in RA Pathogenesis

Gut Microbe, Prevotella copri, Implicated in RA Pathogenesis

August 13, 2017 • By Kathy Holliman

  • Tweet
  • Email
Print-Friendly Version / Save PDF
vrx/shutterstock.com

vrx/shutterstock.com

New research reinforces the hypothesis that the gut microbiome triggers mucosal and systemic immune responses in patients with rheumatoid arthritis. The research, published in Arthritis & Rheumatology May 2017, found that subgroups of patients with RA have differential immunoglobulin G (IgG) or IgA immune reactivity with Prevotella copri, an intestinal microbe that appears to be specific for the disease.1 These observations “provide evidence of the immune relevance of P copri in the pathogenesis of RA,” the investigators say.

You Might Also Like
  • Gene Mutation Could Cause Gut Microbe Changes that Lead to RA
  • Links Between Gut Bacteria and Rheumatoid Arthritis
  • Plasma Cells, Synovial Compartment Implicated in Tenacity of Rheumatoid Arthritis
Explore This Issue
August 2017
Also By This Author
  • Aggressive Urate Lowering Needed for Gout

Lead author Annalisa Pianta, PhD, at Massachusetts General Hospital and Harvard Medical School, says the research she and her colleagues conducted found that about half of patients with RA have T and B cell responses to P copri. Their responses were either IgA antibody responses to P copri, “suggestive of a mucosal immune response, or IgG antibodies to the organism, suggestive of a systemic immune response,” Dr. Pianta says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

For the study, the investigators developed an unbiased, discovery-based approach to identify novel, immunogenic T cell epitopes in patients with chronic inflammatory arthritis. They obtained synovial tissue, synovial fluid mononuclear cells or peripheral blood mononuclear cells from five patients to use for isolation of HLA-DR-presented peptides.

Implicated peptides and their source proteins were tested for immunoreactivity in a larger number of patients, which included a cohort with new-onset RA from whom clinical information, peripheral blood mononuclear cells, serum samples and, for some, synovial fluid samples were available. For comparison, researchers obtained serum samples and peripheral blood mononuclear cells from patients with Lyme arthritis. They also used serum samples from patients with other types of arthritis or connective tissue disease as well as from healthy control subjects.

Dr. Pianta

Dr. Pianta

P copri DNA was detected in synovial fluid in three of the five patients tested who were positive for IgG P copri antibodies, Dr. Pianta says. “These responses appeared to be specific for RA and were not found in patients with other rheumatic diseases or in healthy control subjects.” The frequencies of P copri antibody responses were similar in patients with new-onset RA and those with chronic RA, “suggesting that, once initiated, these antibody responses may persist for years,” the researchers reported.

Previous research by Scher et al in 2013 reported an overexpansion of P copri in patients with new-onset untreated RA compared with patients with chronic RA or psoriatic arthritis or healthy controls.2 According to Dr. Pianta, this “implies that gut dysbiosis may lead to gut inflammation or vice versa, but the reasons for dysbiosis are not yet known. Since P copri overexpansion seems to occur primarily in patients with RA, this likely explains why antibody responses to P copri were rarely found in patients with other rheumatic diseases,” Dr. Pianta says.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Rheumatoid Arthritis Tagged With: ACR Journal, American College of Rheumatology, Diagnosis, gut, intestinal, microbe, Microbiome, Pathogenesis, patient care, Prevotella copri, RA, Research, Rheumatic Disease, Rheumatoid arthritis, rheumatologist, rheumatology, TreatmentIssue: August 2017

You Might Also Like:
  • Gene Mutation Could Cause Gut Microbe Changes that Lead to RA
  • Links Between Gut Bacteria and Rheumatoid Arthritis
  • Plasma Cells, Synovial Compartment Implicated in Tenacity of Rheumatoid Arthritis
  • Microbiome Research Provides Clue to Rheumatoid Arthritis

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)